Changeflow GovPing Healthcare & Life Sciences BECZELTEV Trademark Application for Pharmaceuti...
Routine Notice Added Final

BECZELTEV Trademark Application for Pharmaceutical Preparations

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

USPTO received trademark application TM99424865 for the word mark "BECZELTEV" filed October 2, 2025. The application is classified under Class 5 (pharmaceutical preparations) and covers goods for the treatment of cancer, autoimmune and inflammatory diseases, and infectious diseases. This is an Intent-to-Use application, indicating the applicant plans to use the mark in commerce but has not yet done so.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO Trademark Application TM99424865 for "BECZELTEV" was filed on October 2, 2025. The mark is a standard word mark registered under Nice Classification 5, covering pharmaceutical preparations for treating cancer, autoimmune and inflammatory diseases, and infectious diseases. The application is filed under the Intent-to-Use basis, meaning the applicant has a bona fide intention to use the mark in commerce but has not yet commenced such use.

Affected parties should review whether this application conflicts with existing or pending pharmaceutical trademarks. Competitors may wish to monitor the publication of this application in the Official Gazette to file an opposition if there are grounds. The applicant will need to file a Statement of Use before registration if they proceed under the Intent-to-Use basis. No immediate compliance actions are required as this is an application-stage notice.

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

BECZELTEV

Intent to Use TM99424865 Kind: intenttouse Mar 30, 2026

Abstract

Pharmaceutical preparations for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Filing Date

2025-10-02

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
October 2nd, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99424865

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!